Compare BZH & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZH | VALN |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 767.3M | 653.3M |
| IPO Year | 1995 | 2021 |
| Metric | BZH | VALN |
|---|---|---|
| Price | $33.35 | $6.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $32.00 | $15.50 |
| AVG Volume (30 Days) | ★ 610.1K | 27.1K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,087,739,000.00 | N/A |
| Revenue This Year | $4.36 | N/A |
| Revenue Next Year | $10.79 | $93.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.83 | $4.75 |
| 52 Week High | $34.54 | $12.23 |
| Indicator | BZH | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 60.80 | 52.85 |
| Support Level | $33.07 | $6.29 |
| Resistance Level | $33.34 | $6.60 |
| Average True Range (ATR) | 0.08 | 0.22 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 68.00 | 28.90 |
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.